Cardiorespiratory Fitness Cuts Risk for Poor Cardiovascular Disease Outcomes
By Lori Solomon HealthDay Reporter
WEDNESDAY, May 8, 2024 -- There is consistent evidence that high cardiorespiratory fitness (CRF) is strongly associated with a lower risk for a variety of cardiovascular disease outcomes, according to a review published online May 2 in the British Journal of Sports Medicine.
Justin J. Lang, Ph.D., from the Public Health Agency of Canada in Ottawa, and colleagues conducted a systematic literature review to identify studies evaluating the predictive associations between baseline CRF and health outcomes among adults.
Based on 26 systematic reviews (eight meta-analyses), the researchers found that CRF had the largest risk reduction for all-cause mortality when comparing high versus low CRF (hazard ratio [HR], 0.47). For every 1-metabolic equivalent of task (MET) higher level of CRF, there was a reduction in all-cause mortality (HRs, 0.89 and 0.83, respectively). For specific outcomes, CRF was associated with the largest risk reduction in incident heart failure when comparing high versus low CRF (HR, 0.31). For every 1-MET higher level of CRF, there was a reduction in heart failure (HR, 0.82). Among those living with cardiovascular disease, CRF was associated with the largest risk reduction for cardiovascular mortality when comparing high versus low CRF (HR, 0.27). Evidence across all studies ranged from very low to moderate certainty.
"Through regular assessment, clinicians and exercise professionals could better identify adults at greater risk of early death and initiate exercise programs aimed at increasing CRF through regular physical activity," Lang said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
342 Cardiology Clinics Acquired by Private Equity Firms in 2013 to 2023
WEDNESDAY, July 3, 2024 -- From 2013 to 2023, 342 cardiology clinics were acquired by private equity firms, with 94.7 percent of the acquisitions occurring between 2021 and 2023...
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.